U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07796438) titled 'Low-Frequency rTMS for In-Hospital Sleep Disturbance in Advanced NSCLC' on Aug. 15.
Brief Summary: This randomized, double-blind, sham-controlled trial will evaluate whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve in-hospital sleep quality in adults with advanced non-small cell lung cancer (NSCLC) and clinically significant in-hospital sleep disturbance.
A total of 160 participants with unresectable stage IIIB-IIIC or stage IV NSCLC, or recurrent NSCLC not suitable for curative local treatment, will be randomly assigned in a 1:1 ratio to active rTMS or matched sham stimulation. Active rTMS will...